• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复发性菌血症:一项基于临床和微生物学风险因素的 10 年区域性人群研究。

Recurrent bacteraemia: A 10-year regional population-based study of clinical and microbiological risk factors.

机构信息

National Center for Antimicrobials and Infection Control, Statens Serum Institut, Copenhagen S, Denmark.

出版信息

J Infect. 2010 Mar;60(3):191-9. doi: 10.1016/j.jinf.2009.12.007. Epub 2009 Dec 22.

DOI:10.1016/j.jinf.2009.12.007
PMID:20026352
Abstract

BACKGROUND

A population-based nested case-control study was conducted in order to characterize patient factors and microbial species associated with recurrent bacteraemia.

METHODS

All patients with bacteraemia in a Danish region during 1996-2006 were investigated. Recurrence was defined based on pathogen identity, site of infection and time frame, and not restricted to homologous pathogens.

RESULTS

We identified 8672 patients with first-time bacteraemia, of whom 1003 (12%) had a recurrence within 1 year. The proportion of mono-microbial bacteraemia was similar for first (86%) and recurrent episodes (84%). An unknown focus was common in both episodes (22.7 and 29.1%, respectively). Independent predictors of a recurrence (incidence rate ratio, 95% confidence interval) included health care-associated (2.4; 1.9-3.0) and nosocomial bacteraemia (2.1; 1.8-2.6), poly-microbial Gram-positive bacteraemia (2.7; 1.6-4.6), and fungaemia (2.2; 1.4-3.5), a Charlson co-morbidity index score of 1-2 (1.7; 1.4-2.1), inappropriate empirical antimicrobial chemotherapy (1.3; 1.1-1.5), a gastro-intestinal tract focus (2.3; 1.7-3.0), a liver/biliary tract focus (2.7; 2.0-3.6), an iv-catheter focus (2.0; 1.4-2.8), endocarditis (2.7; 1.6-4.3), and an unknown focus (1.9; 1.5-2.3).

CONCLUSIONS

This study showed recurrent bacteraemia to be common and the following risk factors were identified: a health care-associated or nosocomial origin, poly-microbial or fungal aetiology, a focus within the abdomen, endocardium, iv-catheter-related or unknown, a Charlson co-morbidity index score of >1 and inappropriate empirical antimicrobial chemotherapy.

摘要

背景

为了描述与复发性菌血症相关的患者因素和微生物种类,我们进行了一项基于人群的巢式病例对照研究。

方法

我们调查了丹麦一个地区在 1996-2006 年期间所有发生菌血症的患者。复发的定义基于病原体的身份、感染部位和时间范围,而不限于同源病原体。

结果

我们确定了 8672 例首次菌血症患者,其中 1003 例(12%)在 1 年内复发。首次和复发性感染中单一微生物菌血症的比例相似(分别为 86%和 84%)。两个阶段都常见未知病灶(分别为 22.7%和 29.1%)。复发的独立预测因素(发病率比,95%置信区间)包括与医疗保健相关(2.4;1.9-3.0)和医院获得性菌血症(2.1;1.8-2.6)、多微生物革兰氏阳性菌血症(2.7;1.6-4.6)和真菌感染(2.2;1.4-3.5)、Charlson 合并症指数评分 1-2 分(1.7;1.4-2.1)、经验性抗菌治疗不当(1.3;1.1-1.5)、胃肠道病灶(2.3;1.7-3.0)、肝脏/胆道病灶(2.7;2.0-3.6)、静脉导管病灶(2.0;1.4-2.8)、心内膜炎(2.7;1.6-4.3)和未知病灶(1.9;1.5-2.3)。

结论

本研究表明复发性菌血症较为常见,以下为危险因素:医疗保健相关或医院获得性来源、多微生物或真菌感染、腹部、心内膜、静脉导管相关或未知部位的病灶、Charlson 合并症指数评分>1 分和经验性抗菌治疗不当。

相似文献

1
Recurrent bacteraemia: A 10-year regional population-based study of clinical and microbiological risk factors.复发性菌血症:一项基于临床和微生物学风险因素的 10 年区域性人群研究。
J Infect. 2010 Mar;60(3):191-9. doi: 10.1016/j.jinf.2009.12.007. Epub 2009 Dec 22.
2
Risk factors for recurrence and death after bacteraemia: a population-based study.菌血症后复发和死亡的风险因素:一项基于人群的研究。
Clin Microbiol Infect. 2011 Aug;17(8):1148-54. doi: 10.1111/j.1469-0691.2011.03587.x. Epub 2011 Jun 29.
3
Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.加拿大一个大区域内大肠杆菌血流感染的发病率、危险因素及转归
Clin Microbiol Infect. 2008 Nov;14(11):1041-7. doi: 10.1111/j.1469-0691.2008.02089.x.
4
An analysis of hospital-acquired bacteraemia in intensive care unit patients in a university hospital in Kuwait.科威特一家大学医院重症监护病房患者医院获得性菌血症的分析。
J Hosp Infect. 1999 Sep;43(1):49-56. doi: 10.1053/jhin.1999.0608.
5
Bacteraemia with an unknown focus: is the focus de facto absent or merely unreported? A one-year hospital-based cohort study.不明来源菌血症:病灶是否真的不存在,还是只是未报告?一项为期一年的基于医院的队列研究。
APMIS. 2011 Apr;119(4-5):275-9. doi: 10.1111/j.1600-0463.2011.02727.x. Epub 2011 Mar 22.
6
Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor?铜绿假单胞菌败血症。胆胰疾病是一个危险因素吗?
Med J Aust. 1993 Nov 1;159(9):592-7.
7
Impact of appropriate empirical antibiotic treatment on recurrence and mortality in patients with bacteraemia: a population-based cohort study.恰当的经验性抗生素治疗对菌血症患者复发及死亡率的影响:一项基于人群的队列研究。
BMC Infect Dis. 2017 Feb 6;17(1):122. doi: 10.1186/s12879-017-2233-z.
8
Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.104例单微生物气单胞菌血症的临床特征及治疗意义
J Infect. 2000 May;40(3):267-73. doi: 10.1053/jinf.2000.0654.
9
Sepsis-bacteraemia and other infections due to non-opportunistic bacterial pathogens in a consecutive series of 788 patients hospitalized for HIV infection.
Clin Ter. 1993 Oct;143(4):279-90.
10
Prospective hospital-wide studies of 505 patients with nosocomial bacteraemia in 1997 and 2002.1997年和2002年对505例医院获得性菌血症患者进行的全院前瞻性研究。
J Hosp Infect. 2006 Feb;62(2):230-6. doi: 10.1016/j.jhin.2005.07.007. Epub 2005 Nov 22.

引用本文的文献

1
Antimicrobial Resistance as Risk Factor for Recurrent Bacteremia after Staphylococcus aureus, Escherichia coli, or Klebsiella spp. Community-Onset Bacteremia.金黄色葡萄球菌、大肠埃希菌或肺炎克雷伯菌社区获得性菌血症后复发菌血症的危险因素:抗菌药物耐药性
Emerg Infect Dis. 2024 May;30(5):974-983. doi: 10.3201/eid3005.231555.
2
Prevalence and recurrence of bacteraemia in hospitalised people who inject drugs - a single Centre retrospective cohort study in Denmark.在丹麦,一项单一中心回顾性队列研究显示,住院吸毒者的菌血症患病率和复发率。
BMC Infect Dis. 2020 Aug 26;20(1):634. doi: 10.1186/s12879-020-05357-0.
3
Evaluation of factors for poor outcome in preterm newborns with posthemorrhagic hydrocephalus associated with late-onset neonatal sepsis.
伴有晚发性新生儿败血症的出血后脑积水早产儿预后不良因素的评估。
Ther Clin Risk Manag. 2018 Oct 10;14:1965-1973. doi: 10.2147/TCRM.S177535. eCollection 2018.
4
Risk of drug resistance in repeat gram-negative infections among patients with multiple hospitalizations.多次住院患者重复革兰氏阴性感染的耐药风险。
J Crit Care. 2018 Feb;43:260-264. doi: 10.1016/j.jcrc.2017.09.033. Epub 2017 Sep 18.
5
Impact of appropriate empirical antibiotic treatment on recurrence and mortality in patients with bacteraemia: a population-based cohort study.恰当的经验性抗生素治疗对菌血症患者复发及死亡率的影响:一项基于人群的队列研究。
BMC Infect Dis. 2017 Feb 6;17(1):122. doi: 10.1186/s12879-017-2233-z.
6
Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections.耐多药革兰氏阴性菌引起的血流感染相关成本增加主要归因于医院获得性感染患者。
Antimicrob Agents Chemother. 2017 Feb 23;61(3). doi: 10.1128/AAC.01709-16. Print 2017 Mar.
7
The Danish Collaborative Bacteraemia Network (DACOBAN) database.丹麦菌血症协作网络(DACOBAN)数据库。
Clin Epidemiol. 2014 Sep 18;6:301-8. doi: 10.2147/CLEP.S66998. eCollection 2014.
8
Classification of positive blood cultures: computer algorithms versus physicians' assessment--development of tools for surveillance of bloodstream infection prognosis using population-based laboratory databases.血培养阳性分类:计算机算法与医生评估——基于人群的实验室数据库的血流感染预后监测工具的开发。
BMC Med Res Methodol. 2012 Sep 12;12:139. doi: 10.1186/1471-2288-12-139.
9
Blood culture status and mortality among patients with suspected community-acquired bacteremia: a population-based cohort study.血培养状态与疑似社区获得性菌血症患者的死亡率:一项基于人群的队列研究。
BMC Infect Dis. 2011 May 20;11:139. doi: 10.1186/1471-2334-11-139.
10
Existing data sources for clinical epidemiology: The North Denmark Bacteremia Research Database.现有的临床流行病学数据源:丹麦北部菌血症研究数据库。
Clin Epidemiol. 2010 Aug 9;2:171-8. doi: 10.2147/clep.s10139.